The hepatotoxic response elicited by a chemical agent depends on the concentration of the toxicant (parent compound or metaholite) delivered to the hepatocytes across the liver acinus via blood flow. Hepatotoxicants produce characteristic patterns of cytolethality in specific zones of the acinus due to the differential expression of enzymes and the concentration gradients of cofactors and toxicant in blood across the acinus. Most hepatotoxic chemicals produce necrosis, characterized by swelling in contiguous tracts of cells and inflammation. This process has been contrasted with apoptosis, where cells and organelles condense in an orderly manner under genetic control. Biotransformation can activate a chemical to a toxic metabolite or decrease toxicity. Quantitative or qualitative species differences in biotransformation pathways can lead to significant species differences in hepatotoxicity. Fasted rodents are more susceptible to the hepatotoxic effects of many chemicals due to glutathione depletion and cytochrome P-450 induction. Freshly isolated hepatocytes are the most widely used in vitro system to study mechanisms of cell death. Hepatotoxicants can interact directly with cell macromolecules or via a reactive metabolite. The reactive metabolite can alkylate critical cellular macromolecules or induce oxidative stress. These interactions generally lead to a loss of calcium homeostasis prior to plasma membrane lysis. Mitochondria have been shown to be important cellular targets for many hepatotoxicants. Decreasing hepatocellular adenosine triphosphate concentrations compromise the plasma membrane calcium pump, leading to increased cellular calcium concentrations. Calcium-dependent endonucleases produce double-strand breaks in DNA before cell lysis. These biochemical pathways induced by necrosis-causing toxicants are similar to the biochemical pathways involved in apoptosis, suggesting that apoptosis and necrosis differ in intracellular and extracellular control points rather than in the biochemistry involved in cell death.
A wide variety of chemicals, environmental pollutants, dietary constituents, pharmaceutical agents, and natural products can cause hepatotoxicity in animals and humans. Exposure to hepatotoxic agents is usually accidental, through contaminated food, water, or air or from unanticipated side effects of therapeutic agents. Chemical hepatotoxicity is a dose-and time-dependent phenomenon that is reversible at early stages upon cessation of exposure to the toxicant. However, severe intoxication with hepatotoxic chemicals can lead to liver necrosis and death of the organism if left untreated. Knowledge of the mechanism of action of different hepatotoxic agents is essential for understanding the biochemical events leading to cell death. Understanding the mechanisms of cell death by toxic agents will improve diagnosis of hepatotoxicity and will enable predictions of the potential hepatotoxic effects of chemical agents. Mechanistic information is also required for effective antidotal therapy. In the case of hepatotoxic therapeutic agents, knowledge of mechanisms of toxicity can lead to the development of safer drugs.
The hepatotoxic response elicited by a chemical agent depends on the concentration of the toxicant (either parent compound or toxic metabolite) delivered to the hepatocytes in different regions of the liver acinus via blood flow. The liver acinus consists of parenchyma centered around the terminal branches of the portal vein and hepatic artery (37) . Liver cells are radially arranged in plates along the sinusoids, which drain via the terminal hepatic vein (central vein). Blood flows from the branches of the portal vein and hepatic artery to the central vein, resulting in 3 microcirculatory zones where the e~ l l rcside (37) . The cells in Zone 1 lie closest to the afferent vessels and receive the highest concentrations of oxygen and nutrients. Cells in Zone 2 lie further downstream, and cells in Zone 3 lie near the terminal hepatic v cin. This gradient of oxygen and nutrients leads to a zonation of hepatic intermediary metabolic functions (? 1 ). Hepatocytes from afferent (Zone 1 ) and efferent (Zone 3) zones of the liver acinus differ in enzyme content and metabolic capacity. For example. cells in Zone 1 tend to have more mitochondria and higher respiration rates than cells in Zone 3. However, studies with isolated perfused liver preparations have shown that the rates of metabolic processes across the liver acinus can be shifted by changing the direction of flow from anterograde to retrograde (53) .
These results indicate that most metabolic processes depend on the rate of delivery of cofactors, nutrients, or chemicals (i.e., they are substrate-limited).
The zonation of metabolic functions has important implications for chemically induced toxicity (21, 53) . Hepatotoxicants produce characteristic patterns of cytolethality in specific zones of the acinus due in part to the differential expression of enzymes and the concentration gradients of cofactors and toxicant in blood across the acinus. However, the relationships among these factors are complex, and the underlying reasons for cell-specific toxicity are not well understood.
Most hepatotoxic chemicals produce necrosis. This process generally involves a loss of cellular volume homeostasis in contiguous tracts of cells, resulting in membrane swelling (bleb formation) followed by rupture and destruction of the organelles (11, 60) . Inflammation is usually present. This process has been contrasted with apoptosis (programmed cell death), where cells and organelles condense in an orderly manner under genetic control (60) . During apoptosis, there is activation of a calcium-dependent endonuclease that cleaves DNA and a condensation of cell organelles. Protein synthesis is required in some cases. The affected cell fragments into apoptotic bodies that are phagocytized by neighboring hepatocytes and digested. Unlike necrotic cells, apoptotic cells show no evidence of increased membrane permeability (60) .
BIOTRANSFORMATION OF HEPATOTOXICANTS
The process of biotransformation is intimately involved in chemically induced hepatotoxicity. Most hepatotoxic chemicals are protoxicants that require bioactivation to exert their toxic effects. Metabolism can modulate the properties of hepatotoxic agents in 2 general ways: it can either increase toxicity (toxication or metabolic activation) or decrease toxicity (detoxication) (23) . The toxic potency of a hepatotoxic chemical toward hepatocytes depends on the relative rates of these 2 biotransformation processes.
Biotransformation reactions are of 2 general types, called Phase I reactions and Phase II reactions. Phase I reactions involve oxidations, reductions, and hydrolyses. Many of the oxidation and reduction reactions are catalyzed by the cytochrome P-450-dependent mixed-function oxidase system in the membranes of the endoplasmic reticulum. This nicotinamide adenine dinucleotide phosphate (NADPH)-dependent mixed-function oxidase system consists of the flavoprotein NADPH-cytochrome P-450 reductase and the hemeprotein cytochrome P-450.
The system is termed a mixed-function oxidase because electrons are taken from NADPH to reduce oxygen and oxidize or hydroxylate substrates. Cytochromes P-450 are a superfamily of hemeproteins with overlapping substrate specificity that catalyze a variety of oxidation and reduction reactions, including carbon hydroxylation and the dealkylation of substituted heteroatoms such as N, 0, and S (12, 13, 23, 35) . The biosyntheses of the various cytochrome P-450 isoforms can be induced by treatment with chemicals, including hepatotoxic agents (12, 23) . Enzyme induction can lead to increased or decreased sensitivity of animals to hepatotoxic agents. Sometimes these effects are unanticipated, such as when the inducing agents are present in the diet (23) . The endoplasmic reticulum also contains a second NADPH-dependent mixed-function oxidase system, the flavin-containing monooxygenases, which oxidize amines and sulfur compounds (12, 23) . Phase I reactions generally make chemicals more polar, facilitating their elimination and providing a functional group that can be conjugated with a hydrophilic moiety during Phase II metabolism. Phase I reactions can result in either bioactivation or detoxication depending on the toxicity of the metabolite.
Phase II reactions (also termed synthetic reactions) involve the conjugation of chemicals with hydrophilic moieties such as glutathione, glucuronide, sulfate, or amino acids (20) . These reactions are usually considered detoxication pathways because they result in the formation of a more water-soluble and easily excreted metabolite. However, conjugation reactions can also lead to the formation of unstable precursors to reactive species, in which case they would be bioactivation pathways. For example, the reactive acyl glucuronide metabolite of clofibrate may be involved in the hepatotoxicity of this drug observed in clinical studies (50) . Glutathione conjugation of haloalkanes can result in the formation of glutathionebased sulfur mustards that are thought to be involved in the toxicity and mutagenicity of these compounds (2) . Marked species differences have been observed in the expression of xenobiotic-metabolizing enzymes that can result in species differences in the sensitivity to hepatotoxic agents. The cytochrome P-450 superfamily can display very significant species, strain, and gender differences in expression and catalytic activity (12, 23) . These differences in enzyme expression and substrate specificity can produce qualitative species differences (the metabolic pathway is absent in 1 species) or quantitative species differences (the rate of the pathway is different) in the metabolic pathways involved in the bioactivation or detoxication of hepatotoxicants. Species differences in biotransformation are responsible for most of the known species differences in chemical hepatotoxicity. For example, hamsters and mice are sensitive to the hepatotoxic effects of acetaminophen, whereas rats and humans appear to be resistant. These species differences in hepatotoxicity are largely due to species differences in the rate of production of the toxic metabolite of acetaminophen, N-acetyl-p-benzoquinoneimine (NABQI). Isolated hepatocytes from all 4 species are equally susceptible to the toxic effects of NABQI (51). Another interesting example is the sex difference in the hepatotoxicity of the pyrrolizidine alkaloid senecionine observed in rats, with males being much more sensitive than females. Senecionine requires cytochrome P-450-mediated bioactivation to form a toxic pyrrolic metabolite that interacts with critical cellular macromolecules to produce hepatic cytolethality. Female rats lack the isoform of cytochrome P-450 in-volved in senecionine bioactivation. When female rats are treated with dexamethasone to induce the 3A family of cytochromes P-450, they become as sensitive to senecionine hepatotoxicity as male rats (57) .
The enzymes involved in the biotransformation of toxic chemicals are intimately linked to the processes of cellular intermediary metabolism. In most cases, the ratecontrolling step in biotransformation reactions is cofactor supply (52) . The nutritional state of the animal can have profound effects upon the hepatic concentrations of NADPH and glutathione. Changes in the concentrations of these cofactors can markedly alter the sensitivity of animals to hepatotoxicants. Many investigators fast rodents overnight before orally administering a compound under study so that the absorption of the compound will not be impaired by food in the stomach. However, this practice makes rodents more susceptible to the hepatotoxic effects of many chemicals. Unlike larger animals, an overnight fast decreases hepatic glutathione in rodents by approximately 50% (19) . This severely compromises the ability of rodent liver to detoxicate reactive intermediates. Overnight fasting also induces cytochrome P-450 2E1 (17) . This enzyme is involved in the bioactivation of a wide variety of rodent carcinogens, solvents, and toxicants (14) , so induction of P-450 2E can greatly affect the balance between detoxication and bioactivation.
For example, fed rats are relatively resistant to the hepatotoxic effects of bromobenzene and acetaminophen. After an overnight fast, the rats become extremely susceptible to these hepatotoxicants (34) .
IN VITRO SYSTEMS TO STUDY HEPATOTOXICITY
In vitro systems have been developed to study mechanisms of chemical hepatotoxicity because of the complexity of the whole animal and the experimental difficulty of controlling all the variables that may affect interpretation of the data. In vitro systems are much easier to control than the intact organism and are generally more amenable to precise analytical techniques. Three major experimental systems have been used to study chemical hepatotoxicity: isolated perfused liver preparations, liver slices, and isolated hepatocytes. Each system has its advantages and disadvantages, and the choice of which system to use depends on the experimental questions being asked. The isolated perfused liver preparation allows studies of hepatic function in a physiologically integrated system (59) . However, performing more than 1 set of experiments with each preparation is difficult. Precisioncut liver slices in dynamic culture offer a system that retains cell polarity and the heterogeneity of hepatocyte function (48) . This system bridges the gap between whole organs and isolated cells. One of the disadvantages of this system is that identifying the target cells of chemically induced toxicity using enzyme leakage assays is sometimes difficult. Diffusion of toxicant and nutrients through the slice can also be a problem, and hypoxia can develop. Isolated hepatocytes are easily prepared and easily manipulated for mechanistic studies (44) . Many experiments can be done with the cells isolated from 1 liver.
Hepatocytes are larger and more dense than nonparenchymal cells, enabling rapid purification by low-speed centrifugation. Ho~~e~°er isolated cells lack the anatomical architecture. heterogeneity. and plasma membrane polarity of hepatocytes in iiio. Upon isolation, hepatocytes round out. The polarity of the plasma membrane is lost but region-specific functions are retained t 10>.
Most studies of the mechanisms involved in cell death have been carried out with isolated hepatocvtes. Hepatocytes are prepared by a 2-step perfusion of the liver, first with calcium chelators. to wash out calcium and loosen the tight junctions between the cells, and then with calcium and collagenase, to digest the collagen matrix of the liver (44) . Freshly isolated hepatocytes have been shown to retain the metabolic capacity of the liver both qualitatively and quantitatively (3, 18, 24) . Isolated hepatocytes produce the same array of Phase I and Phase II metabolites as observed in the liver W vivo (3) . Kinetic studies in isolated hepatocytes can accurately predict chemical pharmacokinetics in vivo (18, 24) . This is in contrast to hepatocytes in monolayer culture, which promptly dedifferentiate and lose much of their biotransformation capabilities (47) . There is not only an overall decrease in cytochromes P-450, but also a differential expression of isoforms compared to the intact liver (49) .
The decrease in individual enzyme activities can be modulated by hormonally defined media or culture matrices, but these treatments do not affect all enzyme activities equally. After several days in culture, the endoplasmic reticulum decreases in area, while vacuolization increases (47) . Thus, cultured hepatocytes are not an appropriate in vitro model system for many aspects of chemically induced hepatotoxicity in vivo.
Cytolethality in vitro is generally studied using assays for plasma membrane permeability (5) . The cell is considered dead if the plasma membrane becomes permeable to large molecules such as trypan blue or leaks enzymes such as lactate dehydrogenase. Functional assays can also be used to assess the viability of intermediary metabolic pathways. Adenosine nucleotides can be measured to assess cellular energy capacity. Macromolecular synthesis, mitochondrial activity, and active transport of ions or amino acids can also be measured as indicators of cell functions. Morphological assessments of membrane blebbing or volume changes can also be made. The choice of assays to use once again depends on the experimental questions being asked. It is important to keep the relationship between the experimental question and the measured endpoint in perspective.
MECHANISMS OF HEPATOCELLULAR INJURY AND DEATH
The mechanisms by which hepatotoxic chemicals kill cells can be organized into 4 general nonexclusive areas of increasing complexity. It must be stressed that several of these mechanisms can be operable at the same time with a single toxicant. Sometimes different mechanisms can be operable at different doses of toxicant. Although some mechanisms of chemical toxicity have been identified, the physiological basis for translation of these effects into cytolethality is not well understood and is an active area of research. It is clear. hoBB èB v er. that there is not 1 single button for cell death that 1,-, pushed by the toxicant. It seems likely that a number of critical cellular events could be targets for toxic chemicals in that inactivation or modulation of function could initiate a series of events leading to cell death. A thorough understanding of how the cell regulates its critical functions under normal circumstances is necessary to completely understand the physiological basis for the toxic effects of chemical agents.
The simplest general mechanism involved in cytolethality is a direct effect of the toxicant upon critical cellular systems. Toxicants such as chlorpromazine and other phenothiazines, erythromycin salts, and chenodeoxycholate can have direct surfactant effects on the hepatocyte plasma membrane (43) . These effects will ultimately disrupt cellular volume homeostasis and lead to cell death. The mushroom toxin phalloidin binds to actin and disrupts the cell cytoskeleton, resulting in increased plasma membrane permeability (56) . Various chemicals and metal ions bind to mitochondrial membranes and enzymes, disrupting energy metabolism and cellular respiration. Many hepatotoxic compounds are direct inhibitors and uncouplers of mitochondrial electron transport.
A second general mechanism involved in chemically induced cytolethality is reactive metabolite formation (16, 29) . Many hepatotoxicants such as carbon tetrachloride, allyl alcohol, acetaminophen, and bromobenzene are metabolically activated to chemically reactive toxic species. These chemically reactive metabolites (generally electron-deficient species termed electrophiles) can covalently bind to crucial cellular macromolecules (generally electron-rich species termed nucleophiles) and inactivate critical cellular functions such as ion homeostasis.
Although the covalent binding theory of chemical toxicity may be conceptually satisfying, the critical cellular target for covalent binding has not been identified. It seems unlikely that a single moiety would function as a trigger for cell death by toxic chemicals.
Glutathione is the major cellular nucleophile and provides an efficient detoxication pathway for most electrophilic reactive metabolites (27) . Thus, glutathione depletion can render cells more susceptible to the toxic effects of chemicals (55) . A threshold effect is often seen for chemically induced toxicity until cellular glutathione is depleted. Cellular glutathione can be depleted by alkylating agents, oxidative stress, excess substrates for conjugation, and biosynthetically by administration of the irreversible inhibitor of y-glutamylcysteine synthetase buthionine sulfoximine (26) . Glutathione can be increased by administration of precursors such as N-acetylcysteine and L-2-oxothiazolidine-4-carboxylate. These compounds can be effectively used as antidotes for some hepatotoxic agents such as acetaminophen (58) .
In addition to covalent binding and depletion of glutathione, reactive intermediates can initiate other pathobiological processes such as lipid peroxidation and redox cycling. These processes are involved in the third general mechanism leading to cell death, oxidative stress, which can be defined as an alteration in the intracellular prooxidant-to-antioxidant ratio in favor of prooxidants (46) . Cycling of oxidized and reduced forms of a toxicant such as quinone produces reactive superoxide radical anions FiG. 1. -Redox cycling leading to the formation of reactive oxygen species. A quinone drug is reduced to a semiquinone by a NADPHdependent flavoprotein reductase. The semiquinone reduces molecular oxygen to the superoxide anion radical. Superoxide dismutase forms hydrogen peroxide from superoxide. Hydrogen peroxide can be detoxicated by catalase or glutathione (GSH) peroxidase, or it can react with a metal ion (M) to form hydroxyl radicals. that can lead to the formation of hydrogen peroxide and hydroxyl radicals (Fig. 1) . Metal ions such as iron and copper can participate in redox cycling. The toxic oxygen species produced can deplete glutathione through oxidation, can oxidize critical protein sulfhydryl groups involved in cellular or enzymic regulation, and can initiate lipid peroxidation. Organic hydroperoxides can produce oxidative stress directly through oxidation of critical cellular sulfhydryl groups or initiation of free radical processes.
Lipid peroxidation was once considered the central mechanism of toxicity due to oxidative stress and free radical-producing toxicants such as carbon tetrachloride. In the absence of exogenous iron, however, lipid peroxidation is not very extensive, and its toxicologic significance is unclear. Lipid peroxidation can be important because it can amplify free radical processes, because its products are toxic. and because it can compromise detoxication systems such as glutathione. However, it is difficult to distinguish lipid peroxidation of dead cells from lipid peroxidation involved in cell death. If lipid peroxidation has a causal role in cytolethality, then (a) it should occur in all cases of toxicity by the agent, (b) it should occur before cell death, (c) the extent of peroxidation should correlate with the extent of injury, and (d) agents that prevent lipid peroxidation should protect cells from cytolethality (54) . This reasoning was used by Rush et al (42) in their studies of t-butyl hydroperoxide toxicity toward isolated rat hepatocytes. They found that lipid peroxidation accompanied lactate dehydrogenase release in hepatocytes incubated with t-butyl hydroperoxide. Inclusion of the antioxidant promethazine prevented lipid peroxidation but had no effect on cell death, indicating that lipid peroxidation was not involved in t-butyl hydroperoxide-induced cytolethality. Although lipid peroxidation may be an important mechanism of cytolethality for some agents, considerable evidence shows that lipid peroxidation is not a necessary component of oxidative stress (54) .
The fourth general mechanism involved in chemically induced hepatotoxicity is the disruption of calcium homeostasis (31, 36) . Calcium regulates a wide variety of critical physiological functions in the cell. Calcium homeostasis in the cell is very precisely regulated. The considerable calcium concentration gradient between the inside of the cell (-~-10-' M) and the extracellular fluid (~l 0-3 M) is maintained by an active calcium-effluxing adenosine triphosphatase (ATPase). Thus, this important enzyme system can be a potential target for toxicants. Inside the cell, calcium is sequestered by mitochondria, endoplasmic reticulum, and the nucleus as well as by calcium-binding proteins (31) .
It has long been known that calcium accumulates in necrotic tissue after ischemic or chemical injury, but it was not known whether this accumulation occurred during or after cell death. Recent studies have shown that many hepatotoxic chemicals disrupt cellular calcium homeostasis. Disruption of calcium homeostasis by various means appears to be a common feature of chemical hepatotoxicity, oxidative stress, and anoxic injury (15, 31, 41) . Calcium is released from mitochondria by uncouplers of oxidative phosphorylation, quinones, hydroperoxides, and metal ions such as cadmium and iron. Toxicants such as carbon tetrachloride, bromobenzene, hydroperoxides, and aldehydes release calcium from the endoplasmic reticulum. Many toxicants, including carbon tetrachloride, chloroform, dimethylnitrosamine, and acetaminophen, cause an influx of calcium through the plasma membrane. Other toxicants such as cystamine, diquat, and vanadate ions increase the cellular calcium concentration by inhibiting calcium efflux from the cell.
There are several toxicologic consequences of the disruption of cellular calcium homeostasis ( 15, 31, 36, 41) . Alterations in the cell cytoskeleton can occur. The polymerization state of the protein components of the cytoskeleton is regulated by calcium, so increases in cellular calcium concentration can alter the cytoskeleton. This can lead to plasma membrane blebbing, alterations in plasma membrane channels, and alterations in plasma membrane permeability. A calcium-activated neutral protease has been shown to be involved in the formation of plasma membrane blebs (33) . Increases in calcium can activate both calcium-dependent and calmodulin-dependent phospholipases, leading to a stimulation of arachidonate metabolism and increased plasma membrane permeability. Increased cytoplasmic calcium concentrations can also activate proteases such as calpain. The cytolethality of cystamine appears to be mediated by a calcium-activated neutral protease, as inhibitors of neutral proteases such as antipain and leupeptin protect against cytolethality (32) .
Increased cellular calcium concentrations can also activate endonucleases that degrade DNA (31) . Mounting evidence indicates that DNA is an important cellular target in chemically induced hepatic cell death (6) . It has recently been shown that a wide variety of non-DNA reactive, nonmutagenic cytotoxic agents induce a dramatic loss of cellular ATP and formation of double-strand breaks in hepatocyte DNA prior to the loss of plasma membrane integrity (9) . Chemical agents that have been shown to induce DNA strand breaks in hepatocytes prior to plasma membrane rupture are listed in Table I . These agents include detergents, drugs such as acetaminophen, uncouplers of oxidative phosphorylation, and carcinogens. Elia et al (9) found that mutagenic carcinogens only induced double-strand breaks in DNA at cytotoxic concentrations. At lower noncytotoxic concentrations the carcinogens induced single-strand breaks in DNA from covalent interactions and adduct repair. Mitochondria are important regulators of intracellular calcium concentrations in that they can take up and release calcium, acting as an intracellular buffer (31, 41) .
Hence, mitochondria can be important intracellular targets for toxic chemicals. Acetaminophen is known to deplete hepatocellular protein thiols, increase cytosolic calcium (30) , and inhibit mitochondrial respiration (28) . Hepatic DNA fragmentation induced by acetaminophen (40) is inhibited by calcium channel blockers such as verapamil (38) and endonuclease inhibitors such as aurintricarboxylic acid (45) . These treatments also prevent acetaminophen-induced cytolethality. Inhibition of the DNA repair enzyme poly(ADP-ribose) polymerase increased acetaminophen-induced cytolethality (45) . Similarly, inhibition of endonuclease prevented dimethylnitrosoamine-induced DNA fragmentation and cytolethality (39) , whereas these effects were potentiated by inhibition of DNA repair (22, 39) . These results are consistent with DNA being an important target in chemically induced cell death.
Taken together, these studies suggest a general scenario for hepatocellular death induced by many chemical toxicants. The chemical enters the hepatocyte and may be metabolized to form a toxic, reactive intermediate. The toxicant interacts with critical mitochondrial enzymes or with some component of the ATP-generating systems of the cell, leading to a decrease in cellular ATP This may result from inhibition of electron transport or uncoupling of oxidative phosphorylation. If the interaction is irreversible and irrepairable, then the cell will be committed to a sequence of events leading to plasma membrane rupture and cell death. The decrease in cellular ATP compromises the activity of the ATP-dependent calcium pump of the plasma membrane, and the intracellular calcium concentration rises. Several calcium-dependent degradative enzymes are activated, including endonucleases that cleave DNA. All these events happen before the plasma membrane ruptures. Small amounts of DNA damage can be repaired by the cell, but when DNA damage becomes extensive the cell will die. Extracellular signals are sent during this process to recruit inflammatory cells to remove the damaged hepatocytes.
The cellular biochemistry of cell death induced by necrosis-causing hepatotoxic chemicals is quite similar to the biochemical processes involved in apoptosis. One of the key features of apoptosis is the condensation of chromatin and the cleavage of DNA into nucleosome-sized fragments (1, 7, 60) . Although apoptosis is under more precise genetic control and the degradation of the cell occurs in a much more orderly fashion (suicide) than cell death induced by necrosis-causing chemicals (murder), both processes involve the activation of calcium-dependent endonucleases and early degradation of cellulai DNA (1, 7) . Biosynthesis of a calcium-independent endonuclease is also involved in apoptosis in some cel15 (1) . The elevation of intracellular calcium concentrations in apoptosis appears to be mediated by the biosynthesis of a protein that acts as a calcium pore (1) . Thus, although apoptosis is under precise genetic control, the salient biochemical features of cell death by apoptosis oi necrosis-causing chemicals are qualitatively similar. It iñ ot known whether or not the same endonuclease enzymes are involved in both processes. The major qualmtative difference in biochemical pathways between cel death by apoptosis and necrosis-causing chemicals appears to be in their molecular control points and extracellular signals (1, 7) . Understanding the nature of these control points and their regulation is an active area of research in many laboratories, and our knowledge of the molecular events involved in apoptosis and necrosis is growing rapidly. This knowledge will have practical application for the development of antidotal treatments for chemical intoxication as well as for the development of mechanism-based therapies for diseases such as cancer and AIDS.
